Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018

世界のマウスモデル市場動向及び予測(~2018):タイプ別(近交系、ノックアウト、条件付け)、技術別(マイクロインジェクション、胚性幹細胞)、疾患別(腫瘍学、免疫学、CNS)、サービス別(繁殖、冷凍保存、検疫)、ケア製品別(カゴ、寝床、餌)

◆タイトル:Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018
◆商品コード:BT 2192
◆調査・発行会社:MarketsandMarkets
◆発行日:2014年1月
◆ページ数:339
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single userUSD5,650 ⇒換算¥610,200見積依頼/購入/質問フォーム
Multi User(~5名)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Enterprise Site licence(社内共有可) USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"世界のマウスモデル市場動向及び予測(~2018):タイプ別(近交系、ノックアウト、条件付け)、技術別(マイクロインジェクション、胚性幹細胞)、疾患別(腫瘍学、免疫学、CNS)、サービス別(繁殖、冷凍保存、検疫)、ケア製品別(カゴ、寝床、餌)"について調査・分析し、イントロダクション、エグゼクティブサマリー、市場の機会と課題、市場の動態、技術別分析、製品別分析、サービス別分析、種類別分析、地域別分析、市場規模及び予測、競争状況、市場シェア分析、主要企業(ベンダー)分析等の情報をお届けいたします。

The global mice model market is segmented on the basis of type, technology, disease, and mice model services. By type, the market comprises of inbred, outbred, knockout, conditioned/surgically modified, hybrid/congenic, and spontaneous mutant mice.

The market for mice model services is segmented into breeding, cryopreservation, quarantine, rederivation, genetic testing, model in-licensing, and other services (surgical and line rescue). Based on geography, the market is divided into North America, Europe, Asia, and the Rest of the World (RoW).

The biggest factor that is likely to drive the growth of this market is the ongoing innovations in the development of mice models. In addition, another factor that is likely to drive the growth of the market is the continuous research that is undertaken to develop treatments for fatal diseases such as cancer and HIV/AIDS. Furthermore, research institutes and government bodies have extended their help in the form of investments, funds, and grants, which have stimulated research activities to develop mice models. In addition, the demand for personalized medicines is expected to boost the use of humanized mice models.

A number of factors such as advancements in the biotechnology and biopharmaceutical industries as well as the increase in the number of R&D activities in pharmaceutical industries are propelling the growth of the mice model market. However, stringent regulations and laws for ethical use of animals in research are hindering the growth of this market. In addition, the market is facing a threat from advances in zebrafish models and rat models, which are leading to their increased use in research activities.

North America is the largest market for mice models, followed by Europe and Asia. Furthermore, the Asian and North American markets for mice models are expected to witness a healthy growth over the next five years.

The major players in the market include Charles River Laboratories (U.S.), The Jackson Laboratory (U.S.), Taconic farms, Inc. (U.S.), genOway S.A. (France), Covance, Inc. (U.S.), Crescendo Biologics Limited (U.K.), Deltagen, Inc. (U.S.), Harbour Antibodies BV (The Netherlands), Harlan Laboratories, Inc. (U.S.), TransGenic, Inc. (U.S.), SAGE Labs (U.S.), inGenious Targeting Laboratory, Inc. (U.S.), Lexicon Pharmaceuticals, ImmunoGenes AG (Switzerland), Mirimus, Inc. (U.S.), and Ablexis LLC (U.S.).

Scope of the Report

This research report categorizes the global mice model market into the following segments and sub-segments:

By Type
•Inbred Mice
•Outbred Mice
•Conditioned/Surgically Modified Mice
•Hybrid/Congenic Mice
•Knockout Mice
•Spontaneous Mutant Mice

By Technology
•Microinjection
•Embryonic Stem Cell Injection
•Virus/Vector Mediated Gene Transfer
•Nuclear transfer Technology
•Genetically Modified Sperm
•Others

By Disease
•Oncology
•Immunology & Inflammation
•Central Nervous System
•Cardiovascular
•Diabetes
•Metabolism & Regulation
•Others

By Service
•Breeding
•Cryopreservation
•Quarantine
•Rederivation
•Genetic Testing
•Model In-licensing
•Other Services (Surgical and Line Rescue)

By Geography
•North America
•Europe
•Asia
•RoW

Mice Care Products Market, by Segment
•Bedding
•Feed
•Cages
•Others

【レポートの目次】

1 Introduction (Page No. – 35)
1.1 Markets Covered
1.2 Stakeholders
1.3 Research Methodology

2 Executive Summary (Page No. – 51)

3 Market Dynamics (Page No. – 60)
3.1 Drivers
3.1.1 Ongoing Innovations in Mice Models
3.1.2 Investments and Grants
3.1.3 Personalized Medicine to Fuel The Demand For Personalized Humanized Mice Models
3.1.4 Associations Propelling The Development of Embryonic Stem Cells (Es Cells) As Well As Knockout and Mutant Mice
3.1.5 Global Conferences and Meetings Stimulate Market Growth
3.1.6 Genetic Similarity of Mice to Humans
3.1.7 Advancements in Biotechnology and Biopharmaceutical Industries
3.1.8 Increase in R&D Activities in Pharmaceutical Industries
3.2 Threats
3.2.1 Advances in Zebrafish Model Development
3.2.2 Increased Usage of Rat Models
3.2.3 Increased Benefits From Cryopreservation Is Likely to Hamper The Demand For Mice Models
3.2.4 Alternative Methods to Animal Testing
3.3 Barriers
3.3.1 Regulations and Laws For Ethical Use of Animals in Research
3.4 Opportunities
3.4.1 Upsurge in Research Involving Humanized Mice
3.4.2 Increase In Monoclonal Antibody Production
3.5 Challenges
3.5.1 Need For Improved Mice Models

4 Market Share Analysis, By Key Players (Page No. – 76)

5 Mice Model Market Size (Page No. – 89)
5.1 Market By Type
5.1.1 Introduction
5.1.2 Inbred Mice
5.1.3 Outbred Mice
5.1.4 Hybrid/Congenic Mice
5.1.5 Spontaneous/Mutant Mice
5.1.6 Knockout Mice
5.1.7 Conditioned/Surgically Modified
5.2 Market By Technology
5.2.1 Introduction
5.2.2 Micro-Injection
5.2.3 Embryonic Stem Cell Injection
5.2.4 Nuclear Transferase Technology
5.2.5 Viruses/Vectors
5.2.6 Genetically Modified Sperms
5.2.7 Others
5.3 Market By Disease
5.3.1 Introduction
5.3.2 Oncology
5.3.3 Immunology and Inflammation
5.3.4 Diabetes
5.3.5 Cardiovascular
5.3.6 Central Nervous System
5.3.7 Metabolism and Regulation
5.3.8 Others
5.4 Market By Service
5.4.1 Introduction
5.4.2 Breeding
5.4.3 Cryopreservation
5.4.4 Quarantine
5.4.5 Rederivation
5.4.6 Genetic Testing
5.4.7 Model in Licensing
5.4.8 Others
5.5 Mice Care Products Market, By Segment
5.5.1 Introduction
5.5.2 Cages
5.5.3 Bedding
5.5.4 Feed
5.5.5 Others

6 Geographic Analysis (Page No. – 148)
6.1 Introduction
6.2 North America
6.2.1 Investments in The Development of Mice Models to Increase Their Application Areas
6.2.2 Growing Biomedical Research in The U.S.to Boost The Market
6.2.3 Preclinical Activities By Cros and Pharmaceutical R&D to Propel The Market
6.2.4 Growth in Rare Diseases to Create Demand For Mice Models
6.2.5 Mexico- Production Hub For Global Pharmaceutical Companies
6.3 Europe
6.3.1 Need For Better Mice Models to Trigger Investments and Innovation
6.3.2 Growth in Biosimilars Market Calls For Increased Preclinical Activities
6.3.3 Events Conducted By Animal Care Associations to Promote The Ethical Use of Mice
6.3.4 Increase in Tailored Mice Models For Cancer and Rare Disease Projects
6.4 Asia
6.4.1 Less Stringent Laws Creates A Potential For Outsourcing of Animal Models and Services
6.4.2 Growth in Translational Research in Singapore to Fuel The Market
6.4.3 Increasing R&D Activities Provide Impetus to Preclinical Research
6.4.4 Mandatory Animal Testing For All Pharmaceutical Drugs and Cosmetics in China
6.4.5 Growth in Regenerative Medicine, Biomedical, and Medical Research in Japan
6.4.6 Increase in Neuroscience Research in Malaysia
6.4.7 Government-Supported Strong Academic and Commercial R&D Activities in Taiwan
6.4.8 Rising Pharmaceutical and Biotechnology R&D Activities in Korea
6.5 ROW
6.5.1 Pharmaceutical, Biotechnology, and Research industries in Brazil to Bolster The Market
6.5.2 Ongoing Biomedical Research Activities in Australia and New Zealand to Strengthen The Market
6.5.3 Favorable Business Environment For Pharmaceutical and Biotechnology industries in Saudi Arabia and Uae

7 Competitive Landscape (Page No. – 207)
7.1 Competitive Developments Mapping
7.2 Agreements, Partnerships, Collaborations, and Joint Ventures
7.3 Licensing
7.4 Grants and Funds
7.5 Marketing and Promotion
7.6 Expansions
7.7 Patents
7.8 Others

8 Company Profiles (Page No. – 245)
8.1 Ablexis, LLC
8.2 Charles River Laboratories, Inc.
8.3 Covance, Inc.
8.4 Crescendo Biologics,
8.5 Deltagen, Inc.
8.6 Genoway Sa
8.7 Harbour Antibodies Bv
8.8 Harlan Laboratories, Inc.
8.9 Immunogenes Ag
8.1 Ingenious Targeting Laboratory
8.11 Lexicon Pharmaceuticals, Inc.
8.12 Mirimus, Inc.
8.13 Taconic Farms, Inc.
8.14 The Jackson Laboratory
8.15 Transgenic, Inc.
8.16 Sage Labs

9 Preclinical Pipeline (Page No. – 299)

10 Industry Speaks (Page No. – 314)

11 Cost Assessment and Mouse Model Outlicensing/Buyer Companies Assessment (Page No. – 230)
11.1 Cost of Maintaining A Transgenic Mouse Colony
11.2 List of Mouse Model Outlicensing/Buyer Companies

Table 1 Primary Research – Sampling Frame
Table 2 Global Mice Model and Mice Care Products Market, 2013- 2018 ($Million)
Table 3 Global Mice Model Market, By Geography, 2013-2018 ($Million)
Table 4 Global Market By Type, 2013 – 2018 ($Million)
Table 5 Inbred Market, By Geography, 2013 – 2018 ($Million)
Table 6 Knockout Mice Model Market, By Geography, 2013 – 2018 ($Million)
Table 7 Outbred Mice Model Market, By Geography, 2013 – 2018 ($Million)
Table 8 Hybrid/Congenic Mice Model Market, By Geography, 2013 – 2018 ($Million)
Table 9 Spontenous Mutant Mice Model Market, By Geography, 2013 – 2018 ($Million)
Table 10 Conditioned/Surgically Modified Mice Model Market, By Geography, 2013 – 2018 ($Million)
Table 11 Global Market, By Technology, 2013 – 2018 ($Million)
Table 12 Microinjection Based Mice Model Market, By Geography, 2013 – 2018 ($Million)
Table 13 Embryonic Stem Cell Injection Based Mice Model Market, By Geography, 2013 – 2018 ($Million)
Table 14 Virus/Vector-Mediated Gene Transfer Based Mice Model Market, By Geography, 2013 – 2018 ($Million)
Table 15 Nuclear Transfer Technology Based Mice Model Market, By Geography, 2013 – 2018 ($Million)
Table 16 Genetically Modified Sperm Based Mice Model Market, By Geography, 2013 – 2018 ($Million)
Table 17 Other Technology Based Mice Model Market, By Geography, 2013 – 2018 ($Million)
Table 18 Global Market, By Disease, 2013 – 2018 ($Million)
Table 19 Oncology Mice Model Market, By Geography, 2013 – 2018 ($Million)
Table 20 Immunology & Inflammation Mice Model Market, By Geography, 2013 – 2018 ($Million)
Table 21 Central Nervous System Mice Model Market, By Geography, 2013 – 2018 ($Million)
Table 22 Cardiovascular Mice Model Market, By Geography, 2013 – 2018 ($Million)
Table 23 Diabetes Mice Model Market, By Geography, 2013 – 2018 ($Million)
Table 24 Metabolism & Regulation Mice Model Market, By Geography, 2013 – 2018 ($Million)
Table 25 Other Diseases Mice Model Market, By Geography, 2013 – 2018 ($Million)
Table 26 Global Market, By Service, 2013 – 2018 ($Million)
Table 27 Global Market By Type, By Geography, 2013 – 2018 ($Million)
Table 28 Breeding Services Market, By Geography, 2013 – 2018 ($Million)
Table 29 Cyropreservationservices Market, By Geography, 2013 – 2018 ($Million) 130
Table 30 Quarantine Services Market, By Geography, 2013 – 2018 ($Million)
Table 31 Rederivation Services Market, By Geography, 2013 – 2018 ($Million)
Table 32 Genetic Testingservices Market, By Geography, 2013 – 2018 ($Million)
Table 33 Model in-Licensingservices Market, By Geography, 2013 – 2018 ($Million)
Table 34 Otherservices Market, By Geography, 2013 – 2018 ($Million)
Table 35 Global Mice Care Products Market By Segment, 2013 – 2018 ($Million)
Table 36 Global Mice Care Products Market, By Geography, 2013 – 2018 ($Million)
Table 37 Global Venture Financing For Preclinical Activities in U.S.
Table 38 Innovation Centers Set Up in U.S.
Table 39 Collaborations For Preclinical Activities in The Year 2013 For U.S. Based Companies
Table 40 Grants and Contracts For Preclinical Activities in U.S.
Table 41 Cages Market, By Geography, 2013 – 2018 ($Million)
Table 42 Bedding Market, By Geography, 2013 – 2018 ($Million)
Table 43 Feed Market, By Geography, 2013 – 2018 ($Million)
Table 44 Other Care Products Market, By Geography, 2013 – 2018 ($Million)
Table 45 Global Mice Model Market, $Million (2013 -2018)
Table 46 Nih Funding For Projects Related to Animal Models
Table 47 Associations Directly Related to The Animal Model Market With Event Dates
Table 48 Associations indirectly Related to The Animal Model Market With Event Dates
Table 49 Distribution of Products and Projects By Phase (December 2011)
Table 50 North America : Mice Model Market, $Million (2013 -2018)
Table 51 North America : Market, By Type, $Million (2013 -2018)
Table 52 North America : Market, By Technology, $Million (2013 -2018)
Table 53 North America : Market, By Disease, $Million (2013 -2018)
Table 54 North America : Market, By Service, $Million (2013 -2018)
Table 55 North America : Mice Care Products Market, By Segment, $Million (2013 -2018)
Table 56 Biosimilars Pipeline - European Region -2011
Table 57 Biosimilars Under Review By Ema -2013
Table 58 Events Conducted By Animal Care Associations to Promote The Ethical Use of Mice
Table 59 EU-Funded Projects For Rare Diseases That Made Use of Mice Models
Table 60 Europe: Mice Model Market, $Million (2013 -2018)
Table 61 Europe: Market, By Type, $Million (2013 -2018)
Table 62 Europe: Market, By Technology, $Million (2013 -2018)
Table 63 Europe: Market, By Disease, $Million (2013 -2018)
Table 64 Europe: Market, By Service, $Million (2013 -2018)
Table 65 Europe: Mice Care Products Market, By Segment, $Million (2013 -2018)
Table 66 AAALAC - Accredited Companies/institutes/Organizations/Universities, By Geography
Table 67 Number of Guidelines/Associations For Regulatory Care of Animals, By Geography
Table 68 Significant Funding Activities in Translational Research in Singapore
Table 69 Global Researcher Views of Leading Countries in R&D By Research/Technology Area
Table 70 R & D Trend in india
Table 71 Research Partnerships With Japan
Table 72 Research Projects Conducted At The Universiti Putra Malaysia
Table 73 Asia: Mice Model Market, $Million (2013 -2018)
Table 74 Asia: Market, By Type, $Million (2013 -2018)
Table 75 Asia: Market, By Technology, $Million (2013 -2018)
Table 76 Asia: Market, By Disease, $Million (2013 -2018)
Table 77 Asia: Market, By Service, $Million (2013 -2018)
Table 78 Asia: Mice Care Products Market, By Segment, $Million (2013 -2018)
Table 79 List of institutes Partnered Or Affiliated With The Australian Phenomics Network
Table 80 ROW: Mice Model Market, $Million (2013 -2018)
Table 81 ROW: Market, By Type, $Million (2013 -2018)
Table 82 ROW: Market, By Technology, $Million (2013 -2018)
Table 83 ROW: Market, By Disease, $Million (2013 -2018)
Table 84 ROW: Market, By Service, $Million (2013 -2018)
Table 85 ROW: Mice Care Products Market, By Segment, $Million (2013 -2018)
Table 86 Agreements, Partnerships, Collaborations, and Joint Ventures (2010 – 2013)
Table 87 Licensing (2010–2013)
Table 88 Grants and Funds (2010 – 2013)
Table 89 Marketing and Promotion (2010 – 2013)
Table 90 Expansions (2010 – 2013)
Table 91 Patents (2010 – 2013)
Table 92 New Product Launches (2010 – 2013)
Table 93 Others (2010 – 2013)
Table 94 Charles River Laboratories, Inc.: Products
Table 95 Charles River Laboratories, Inc.: Services
Table 96 Covance, Inc.: Services
Table 97 Covance, Inc.: Strategy
Table 98 Genoway S.A.: Products
Table 99 Genoway S.A.: Services
Table 100 Genoway S.A.: Technologies For Creating Mice Models
Table 101 Harlan Laboratories, Inc. : Products
Table 102 Harlan Laboratories, Inc. : Services
Table 103 Harlan Laboratories, Inc. : Mice Care Products
Table 104 Sage Labs : Products
Table 105 Sage Labs : Services
Table 106 Taconic Farms : Products
Table 107 Taconic Farms : Services
Table 108 The Jackson Laboratory : Products
Table 109 The Jackson Laboratory : Services
Table 110 Transgenic, Inc. : Products
Table 111 Transgenic, Inc. : Services
Table 112 List of Companies With Preclinical Pipeline (2010 – 2013)
Table 113 Cost of Maintaining A Transgenic Mouse Colony
Table 114 Cost of Production of Transgenic Mice
Table 115 Cost of Sevices For Transgenic Mice
Table 116 List of Mice Model Out Licensing and Buyer Companies


List Of Figures (85 Figures)

Figure 1 Market Segmentation
Figure 2 Key Stakeholders
Figure 3 Research Methodology- Market Size Estimation
Figure 4 Research Methodology- Market Sizing
Figure 5 Research Methodology- Competitive Assessment
Figure 6 Research Methodology- Data Triangulation
Figure 7 Research Methodology- Secondary Research Procedure
Figure 8 Global Mice Model Market, By Type, 2013 ($Million)
Figure 9 Global Market, By Services, 2013 ($Million)
Figure 10 Global Market, By Geography, 2013 ($Million)
Figure 11 Market Share, By Company (in Terms of $Value), 2013
Figure 12 Competitive Positioning, By Company (2010 – 2013)
Figure 13 Mice Model Market (Inclusive of Models and Services, Based On Value, 2012)
Figure 14 Mice Model Market Segmentation, By Type
Figure 15 Inbred and Knockout Mice Model Market, $Million (2013 – 2018)
Figure 16 Mice Model Market Segmentation, By Technology 103
Figure 17 Microinjection and Embryonic Stem Cell Based Mice Model Market, $Million (2013 – 2018)
Figure 18 Mice Model Market, By Disease
Figure 19 Oncology and Immunology and Inflammation Mice Model Market, 2013 – 2018 ($Million)
Figure 20 Mice Model Market Segmentation, By Service
Figure 21 Inbred and Knockout Mice Model Market, $Million (2013 - 2018)
Figure 22 Comparison of Global Mice Model Market By Services, By Geography (For The Year 2013 and 2018)
Figure 23 Mice Care Products Market, By Segment
Figure 24 Cages and Feed Market, $Million (2013 - 2018)
Figure 25 Comparison of Global Mice Care Products Market, By Geography (For The Year 2013 and 2018)
Figure 26 Tapped/Matured and Untapped/Potential Markets
Figure 27 Mice Model Market, By Geography
Figure 28 Mice Model Market Geographic Analysis
Figure 29 Scientific R&D Spending, By Country
Figure 30 Competitive Developments Mapping (top Five Players For Each Key Growth Strategy)
Figure 31 Share of Key Strategies (2010 – 2013
Figure 32 Most Active Companies (2010 – 2013)
Figure 33 Share of Agreements, Partnerships, Collaborations, and Joint Ventures (2010– 2013)
Figure 34 Share of Licensing (2010–2013)
Figure 35 Share of Grants and Funds (2010 – 2013)
Figure 36 Share of Marketing and Promotion (2010 – 2013)
Figure 37 Share of Expansions (2010 – 2013)
Figure 38 Share of Patents (2010 – 2013)
Figure 39 Share of New Product Launches (2010 – 2013)
Figure 40 Share of Others (2010 – 2013)
Figure 41 Ablexis Llc : Geographic Presence
Figure 42 Ablexis Llc : Strategy
Figure 43 Charles River Laboratories, Inc.: Geographic Presence
Figure 44 Charles River Laboratories, Inc.: total Revenue, 2010 – 2012 ($Million )
Figure 45 Charles River Laboratories, Inc.: total Revenue, By Segment, 2010 – 2012 ($Million )
Figure 46 Charles River Laboratories, Inc.: Total Revenue, By Geography, 2010 – 2012 ($Million )
Figure 47 Covance, Inc.: Geographic Presence
Figure 48 Covance, Inc.: Total Revenue, 2010 – 2012 ($Million )
Figure 49 Covance, Inc.: Total Revenue, By Segment, 2010 – 2012 ($Million )
Figure 50 Covance, Inc.: Total Revenue, By Geography, 2010 – 2012 ($Million )
Figure 51 Crescendo Biologics: Geographic Presence
Figure 52 Crescendo Biologics: Strategy
Figure 53 Deltage N, Inc.: Geographic Presence
Figure 54 Deltagen, Inc.: Total Revenue, 2010 – 2012 ($Million )
Figure 55 Deltage N, Inc.: Strategy
Figure 56 Genoway S.A.: Geographic Presence
Figure 57 Genoway S.A.: Total Revenue, 2010 – 2012 ($Million )
Figure 58 Genoway S.A.: Total Revenue, By Geography, 2010 – 2012 ($Million )
Figure 59 Genoway S.A.: Strategy
Figure 60 Harbour Antibodies Bv : Geographic Presence
Figure 61 Harbour Antibodies Bv : Strategy
Figure 62 Harlan Laboratories, Inc. : Geographic Presence
Figure 63 Harlan Laboratories, Inc. : Strategy
Figure 64 Immunogenes Ag : Geographic Presence
Figure 65 Immunogenes Ag : Strategy
Figure 66 Ingenious Targeting Laboratory : Geographic Presence
Figure 67 Ingenious Targeting Laboratory : Stratgey
Figure 68 Lexicon Pharmaceuticals : Geographic Presence
Figure 69 Lexicon Pharmaceuticals : Total Revenue, 2010 – 2012 ($Million )
Figure 70 Lexicon Pharmaceuticals : Total Revenue, By Segment, 2010 – 2012 ($Million )
Figure 71 Lexicon Pharmaceuticals : Strategy
Figure 72 Mirimus : Geographic Presence
Figure 73 Mirimus : Strategy
Figure 74 Sage Labs : Geographic Presence
Figure 75 Sage Labs : Strategy
Figure 76 Taconic Farms : Geographic Presence
Figure 77 Taconic Farms : Strategy
Figure 78 The Jackson Laboratory : Geographic Presence
Figure 79 The Jackson Laboratory : Total Revenue, 2010 – 2012 ($Million )
Figure 80 The Jackson Laboratory : Total Revenue, By Segment, 2010 – 2012 ($Million )
Figure 81 The Jackson Laboratory : Strategy
Figure 82 Immunodeficient and Humanized Mouse Model Development Timeline
Figure 83 Transgenic, Inc. : Geographic Presence
Figure 84 Transgenic, Inc. : Strategy
Figure 85 Colony Maintenance Types and Levels


★調査レポート[世界のマウスモデル市場動向及び予測(~2018):タイプ別(近交系、ノックアウト、条件付け)、技術別(マイクロインジェクション、胚性幹細胞)、疾患別(腫瘍学、免疫学、CNS)、サービス別(繁殖、冷凍保存、検疫)、ケア製品別(カゴ、寝床、餌)] ( Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018 / BT 2192) 販売に関する免責事項
[世界のマウスモデル市場動向及び予測(~2018):タイプ別(近交系、ノックアウト、条件付け)、技術別(マイクロインジェクション、胚性幹細胞)、疾患別(腫瘍学、免疫学、CNS)、サービス別(繁殖、冷凍保存、検疫)、ケア製品別(カゴ、寝床、餌)] ( Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018 / BT 2192) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆